Skip to content
Home - Media - Press releases - 1999    
12 February 1999
ASTRAZENECA MERGER - COMPETITION AUTHORITY APPROVAL PROGRESS

Astra AB announce that Astra and Zeneca confirm that the period for the European Commission's Phase I review of the proposed merger has been extended to 1st March 1999. This is to enable the parties and the Commission to discuss certain minor aspects of the merger further.

The parties expect to make an announcement regarding progress with the U.S. competition authorities shortly.

The parties continue to expect the merger to be implemented in Q2 1999 as previously indicated.

AstraZeneca websites
Search